These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25109674)

  • 1. Neuroimaging indicators of the performance of instrumental activities of daily living in Alzheimer's disease combined with cerebrovascular disease.
    Chen YK; Xiao WM; Li WY; Liu YL; Li W; Qu JF; Fang XW; Weng HY; Ungvari GS; Xiang YT
    Geriatr Gerontol Int; 2015 May; 15(5):588-93. PubMed ID: 25109674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.
    Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E
    J Neurol Sci; 2012 Nov; 322(1-2):96-101. PubMed ID: 22959283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Instrumental activities of daily living in Parkinson's disease dementia as compared with Alzheimer's disease: relationship to motor disability and cognitive deficits: a pilot study.
    Rasovska H; Rektorova I
    J Neurol Sci; 2011 Nov; 310(1-2):279-82. PubMed ID: 21851954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional status assessment during Alzheimer's disease: results after one year (the REAL French Study Group).
    Guerin O; Soto ME; Brocker P; Robert PH; Benoit M; Vellas B;
    J Nutr Health Aging; 2005; 9(2):81-4. PubMed ID: 15791350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).
    Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS;
    J Nutr Health Aging; 2005; 9(2):106-11. PubMed ID: 15791354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological screening performance and the association with activities of daily living and instrumental activities of daily living in dementia: baseline and 18- to 24-month follow-up.
    Monaci L; Morris RG
    Int J Geriatr Psychiatry; 2012 Feb; 27(2):197-204. PubMed ID: 22223145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension, white matter change and response to cholinesterase inhibitors in Alzheimer's disease.
    Connelly PJ; Prentice NP; Fowler KG
    Int J Geriatr Psychiatry; 2005 Jul; 20(7):623-8. PubMed ID: 16021654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between quality of life, Mini-Mental State Examination, and the Instrumental Activities of Daily Living in patients with Alzheimer's disease.
    Wlodarczyk JH; Brodaty H; Hawthorne G
    Arch Gerontol Geriatr; 2004; 39(1):25-33. PubMed ID: 15158578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poststroke fatigue: risk factors and its effect on functional status and health-related quality of life.
    Chen YK; Qu JF; Xiao WM; Li WY; Weng HY; Li W; Liu YL; Luo GP; Fang XW; Ungvari GS; Xiang YT
    Int J Stroke; 2015 Jun; 10(4):506-12. PubMed ID: 25472471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Reserve: Experience Participating in Instrumental Activities of Daily Living is Associated with Gender and Functional Independence in Mild Cognitive Impairment.
    Berezuk C; Zakzanis KK; Ramirez J; Ruocco AC; Edwards JD; Callahan BL; Black SE;
    J Alzheimers Dis; 2017; 58(2):425-434. PubMed ID: 28453478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Planning and activities of daily living in Alzheimer's disease and frontotemporal dementia].
    Piquard A; Derouesné C; Lacomblez L; Siéroff E
    Psychol Neuropsychiatr Vieil; 2004 Jun; 2(2):147-56. PubMed ID: 15683978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of HMG-CoA reductase inhibitors on cognition in patients with Alzheimer's dementia: a prospective withdrawal and rechallenge pilot study.
    Padala KP; Padala PR; McNeilly DP; Geske JA; Sullivan DH; Potter JF
    Am J Geriatr Pharmacother; 2012 Oct; 10(5):296-302. PubMed ID: 22921881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clock drawing test in mild and moderate dementia of the Alzheimer's type: a comparative and correlation study.
    Heinik J; Solomesh I; Shein V; Becker D
    Int J Geriatr Psychiatry; 2002 May; 17(5):480-5. PubMed ID: 11994938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between non-cognitive symptoms and functional impairment in Alzheimer's disease.
    Mok WY; Chu LW; Chung CP; Chan NY; Hui SL
    Int J Geriatr Psychiatry; 2004 Nov; 19(11):1040-6. PubMed ID: 15481076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective study on the benefits of combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: the MEMAGE study.
    Gareri P; Putignano D; Castagna A; Cotroneo AM; De Palo G; Fabbo A; Forgione L; Giacummo A; Lacava R; Marino S; Simone M; Zurlo A; Putignano S
    J Alzheimers Dis; 2014; 41(2):633-40. PubMed ID: 24643135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter lesions are related to impaired instrumental activities of daily living poststroke.
    Pohjasvaara TI; Jokinen H; Ylikoski R; Kalska H; Mäntylä R; Kaste M; Erkinjuntti T
    J Stroke Cerebrovasc Dis; 2007; 16(6):251-8. PubMed ID: 18035242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive geriatric assessment in female elderly patients with Alzheimer disease and other types of dementia.
    Riccio D; Solinas A; Astara G; Mantovani G
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():343-53. PubMed ID: 17317473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional correlates of instrumental activities of daily living in mild Alzheimer's disease.
    Nadkarni NK; Levy-Cooperman N; Black SE
    Neurobiol Aging; 2012 Jan; 33(1):53-60. PubMed ID: 20359778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient and caregiver outcomes after 6 +/- 1.5-months of rivastigmine therapy for mild-to-moderate Alzheimer's disease: the Belgian FExT study.
    Mets T; Vandewoude M; Jacquy J; Deblander A; MacDonald K; Sloesen A; Abraham I;
    Curr Med Res Opin; 2007 Oct; 23(10):2485-501. PubMed ID: 17784995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations in activities of daily living and instrumental activities of daily living capacity in a representative sample: disentangling dementia- and mobility-related effects.
    Wilms HU; Riedel-Heller SG; Angermeyer MC
    Compr Psychiatry; 2007; 48(1):95-101. PubMed ID: 17145288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.